查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1416700

肝癌诊断市场报告：2030 年趋势、预测与竞争分析

Liver Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

肝癌诊断趋势与预测

预计到 2030 年，全球肝癌诊断市场将达到 110 亿美元，2024 年至 2030 年复合年增长率为 6.2%。该市场的主要驱动因素是肝癌相关发病率的增加以及对快速筛检方法和就地检验的需求不断增加。全球肝癌诊断市场的未来前景广阔，医院和诊断实验室、学术研究机构、製药和 CRO 实验室市场都充满机会。

肝癌诊断市场洞察

Lucintel 预测，由于实验室检测的准确性和成本效益，公众越来越偏好实验室筛检，因此实验室筛检将在整个预测期内继续成为最大的细分市场。

在这个市场中，医院和诊断实验室在整个预测期内仍将是最大的部分。

由于健康的医疗保健环境、人们越来越多地采用医疗保险以及该地区主要企业的存在，预计北美在预测期内将出现最高的增长。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球肝癌诊断市场预计将达到 110 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球肝癌诊断市场预计将以6.2%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动力是肝癌相关发生率的增加以及对快速筛检方法和就地检验的需求不断增加。

Q4.市场的主要细分市场是：

A4. 肝癌诊断市场的未来前景广阔，医院和诊断实验室、学术研究机构、製药和 CRO 实验室市场都有机会。

Q5.市场的主要企业是：

A5. 主要肝癌诊断公司如下。

  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Qiagen
  • Thermo Fisher Scientific
  • Siemens Healthineers

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计，由于实验室检测的准确性和成本效益，公众越来越偏好实验室筛检，因此实验室筛检将在整个预测期内继续成为最大的细分市场。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于拥有强大的医疗保健环境、人们越来越多地采用医疗保险以及该地区主要企业的存在，预计北美地区将在预测期内实现最高的增长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球肝癌诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球肝癌诊断市场趋势（2018-2023）与预测（2024-2030）
  • 按测试类型分類的全球肝癌诊断市场
    • 临床检查
    • 诊断影像
    • 内视镜检查
    • 切片检查
    • 其他的
  • 按最终用途分類的全球肝癌诊断市场
    • 医院和诊断实验室
    • 学术研究所
    • 製药与CRO研究所

第四章 2018-2030年区域市场趋势及预测分析

  • 全球肝癌诊断市场（按地区）
  • 北美洲肝癌诊断市场
  • 欧洲肝癌诊断市场
  • 亚太肝癌诊断市场
  • 其他地区肝癌诊断市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按测试类型分類的全球肝癌诊断市场成长机会
    • 按最终用途分類的全球肝癌诊断市场成长机会
    • 全球肝癌诊断市场按地区成长机会
  • 全球肝癌诊断市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球肝癌诊断市场的产能
    • 全球肝癌诊断市场的併购和合资企业
    • 认证和许可

第七章主要企业概况

  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Qiagen
  • Thermo Fisher Scientific
  • Siemens Healthineers
简介目录

Liver Cancer Diagnostic Trends and Forecast

The future of the global liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets. The global liver cancer diagnostic market is expected to reach an estimated $11.0 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are rising number of incidence related to liver cancer and growing demand for rapid screening methods & point-of-care tests.

A more than 150-page report is developed to help in your business decisions.

Liver Cancer Diagnostic by Segment

The study includes a forecast for the global liver cancer diagnostic by test type, end use, and region.

Liver Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Laboratory Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Others

Liver Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & CRO Laboratories

Liver Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Liver Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies liver cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the liver cancer diagnostic companies profiled in this report include-

  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Qiagen
  • Thermo Fisher Scientific
  • Siemens Healthineers

Liver Cancer Diagnostic Market Insights

Lucintel forecasts that laboratory test will remain the largest segment over the forecast period due to its rising preference among general public because of its precision and cost-effectiveness.

Within this market, hospitaland diagnostic laboratory will remain the largest segment over the forecast period.

North America is expected to witness highest growth over the forecast period due to existence of robust healthcare settings, rising adoption of healthcare insurance policies among the population, and presence of key players in the region.

Features of the Global Liver Cancer Diagnostic Market

Market Size Estimates: Liver cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Liver cancer diagnostic market size by test type, end use, and region in terms of value ($B).

Regional Analysis: Liver cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test types, end uses, and regions for the liver cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the liver cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the liver cancer diagnostic market size?

Answer: The global liver cancer diagnostic market is expected to reach an estimated $11.0 billion by 2030.

Q2. What is the growth forecast for liver cancer diagnostic market?

Answer: The global liver cancer diagnostic market is expected to grow with a CAGR of 6.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the liver cancer diagnostic market?

Answer: The major drivers for this market are rising number of incidence related to liver cancer and growing demand for rapid screening methods & point-of-care tests.

Q4. What are the major segments for liver cancer diagnostic market?

Answer: The future of the liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets.

Q5. Who are the key liver cancer diagnostic market companies?

Answer: Some of the key liver cancer diagnostic companies are as follows:

  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Qiagen
  • Thermo Fisher Scientific
  • Siemens Healthineers

Q6. Which liver cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that laboratory test will remain the largest segment over the forecast period due to its rising preference among general public because of its precision and cost-effectiveness.

Q7. In liver cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of robust healthcare settings, rising adoption of healthcare insurance policies among the population, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the liver cancer diagnostic market by test type (laboratory tests, imaging, endoscopy, biopsy, and others), end use (hospitals & diagnostic laboratories, academic & research institutes, and pharmaceutical & CRO laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Liver Cancer Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Liver Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Liver Cancer Diagnostic Market by Test Type
    • 3.3.1: Laboratory Tests
    • 3.3.2: Imaging
    • 3.3.3: Endoscopy
    • 3.3.4: Biopsy
    • 3.3.5: Others
  • 3.4: Global Liver Cancer Diagnostic Market by End Use
    • 3.4.1: Hospitals & Diagnostic Laboratories
    • 3.4.2: Academic & Research Institutes
    • 3.4.3: Pharmaceutical & CRO Laboratories

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Liver Cancer Diagnostic Market by Region
  • 4.2: North American Liver Cancer Diagnostic Market
    • 4.2.2: North American Liver Cancer Diagnostic Market by End Use: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & CRO Laboratories
  • 4.3: European Liver Cancer Diagnostic Market
    • 4.3.1: European Liver Cancer Diagnostic Market by Test Type: Laboratory Tests, Imaging, Endoscopy, Biopsy, and Others
    • 4.3.2: European Liver Cancer Diagnostic Market by End Use: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & CRO Laboratories
  • 4.4: APAC Liver Cancer Diagnostic Market
    • 4.4.1: APAC Liver Cancer Diagnostic Market by Test Type: Laboratory Tests, Imaging, Endoscopy, Biopsy, and Others
    • 4.4.2: APAC Liver Cancer Diagnostic Market by End Use: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & CRO Laboratories
  • 4.5: ROW Liver Cancer Diagnostic Market
    • 4.5.1: ROW Liver Cancer Diagnostic Market by Test Type: Laboratory Tests, Imaging, Endoscopy, Biopsy, and Others
    • 4.5.2: ROW Liver Cancer Diagnostic Market by End Use: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & CRO Laboratories

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Liver Cancer Diagnostic Market by Test Type
    • 6.1.2: Growth Opportunities for the Global Liver Cancer Diagnostic Market by End Use
    • 6.1.3: Growth Opportunities for the Global Liver Cancer Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Liver Cancer Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Liver Cancer Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Liver Cancer Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Qiagen
  • 7.4: Thermo Fisher Scientific
  • 7.5: Siemens Healthineers